New number of shares and votes in Swedish Orphan Biovitrum AB (publ)
As per 30 September 2020, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi™) amounts to 303,815,511 shares. All shares are common shares. The total number of votes is 303,815,511. The increase in the number of shares and votes results from an issue of 3,837,672 class C shares. The class C shares have been issued for the purpose of ensuring fulfilment of commitments under incentive programmes and have by virtue of the conversion clause in the articles of association been converted to common shares. As per 30 September 2020 the company holds 8,918,672 common shares.
Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. Sobi is providing sustainable access to innovative therapies in the areas of haematology, immunology and specialty indications. Today, Sobi employs approximately 1,400 people across Europe, North America, the Middle East, Russia and North Africa. In 2019, Sobi’s revenues amounted to SEK 14.2 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. You can find more information about Sobi at sobi.com.
For more information please contact
|Paula Treutiger, Head of Communication & Investor Relations|
|+46 733 666 599|
|Linda Holmström, Corporate Communications & Investor Relations|
|+46 708 734 095|
The above information has been made public in accordance with the Swedish Financial Instruments Trading Act. The information was released for public distribution on 30 September 2020 at 08:00 CEST.
Swedish Orphan Biovitrum AB (publ)
Postal address SE-112 76 Stockholm, Sweden
Phone: 46 8 697 20 00 www.sobi.com